Thursday, August 17
Patient Management in High-Risk Neuroblastoma — A Look at the Literature Non-CNE Lunch Symposium (SYMTHL)
Managing high-risk neuroblastoma patients receiving antibody therapy can be complex. Learn more about caring for these patients as we take an in-depth look at recently published literature. Hear directly from the authors as they discuss their institution-specific nursing practice guidelines.
Please note that while this optional event is included in the conference fee, selecting the event on the registration form is required to attend. Space is limited.
APHON thanks United Therapeutics for their generous support of this event.